Particle.news

Download on the App Store

Serena Williams Discloses GLP-1 Use After 14-Kilogram Weight Loss

She describes improved mobility and uses new interviews and Instagram to push back on stigma around the medications.

Image
Image
Image

Overview

  • Williams says she struggled to reach her target weight after her first childbirth in 2017 and turned to a GLP-1 therapy this year following continued training and dietary efforts.
  • She reports losing about 14 kilograms since January and says her joints feel better and she can run farther than before.
  • In remarks to outlets including Vogue, People and Women’s Health, she stresses transparency and rejects the notion that the injections are an easy shortcut.
  • Coverage explains that GLP-1 drugs such as semaglutide mimic a gut hormone to reduce appetite, slow gastric emptying and aid blood-sugar control, with effectiveness supported by ongoing use alongside exercise and diet.
  • GALA and Promiflash report she accessed treatment through Ro, a telehealth platform offering GLP-1 options in which her husband Alexis Ohanian is an investor.